Generics controversy issue widens

Jun 05, 2006

A dispute between the U.S. Justice Department and Federal Trade Commission over generic drugs is reportedly widening with implications for the drug firms.

The issue relates to the legality of deals between drug companies and those making the generic versions, reports the Financial Times. As the controversy heats up, the FTC, over the objections of the Bush administration, may file a second petition urging the Supreme Court to decide the issue.

The Financial Times report says the rift between the two departments results from a complex patent dispute involving a company and a drug for treating the side effects of blood pressure medicines. The FTC claims a deal the company and a generic rival made subsequently is anti-competitive.

The report says while settlements between drug companies do not usually violate antitrust laws, they do when branded drug groups offer their generic rivals deals to stay out of the market until a certain date.

Copyright 2006 by United Press International

Explore further: Older people at higher risk of emergency cancer diagnosis

Related Stories

Smart crystallization

Mar 02, 2015

A novel nucleating agent that builds on the concept of molecularly imprinted polymers (MIPs) could allow crystallographers access to proteins and other biological macromolecules that are usually reluctant ...

Body by smartphone

Jul 30, 2014

We love our smartphones. Since they marched out of the corporate world and into the hands of consumers about 10 years ago, we've relied more and more on our iPhone and Android devices to organize our schedules, ...

Merck 2Q profit more than doubles

Jul 29, 2014

A big one-time gain and a tax benefit helped drugmaker Merck & Co. more than double its second-quarter profit, raise the lower end of its profit forecast and easily top analysts' expectations.

Recommended for you

Quality improvement intervention cuts tests ordered

2 hours ago

(HealthDay)—Implementation of a multifaceted quality improvement intervention is associated with a decrease in the number of ordered laboratory tests, according to a study published online March 21 in the ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.